The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 12, 2025

Filed:

Jan. 06, 2025
Applicant:

Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA (US);

Inventors:

Jack Yongfeng Zhang, Rancho Cucamonga, CA (US);

Ying Wang, Rancho Cucamonga, CA (US);

Ray Lameng Lei, Rancho Cucamonga, CA (US);

Mary Zi-Ping Luo, Rancho Cucamonga, CA (US);

Assignee:

Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/137 (2006.01); A61K 9/00 (2006.01); A61K 47/06 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/34 (2017.01);
U.S. Cl.
CPC ...
A61K 31/137 (2013.01); A61K 9/0075 (2013.01); A61K 47/06 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/34 (2013.01);
Abstract

Pharmaceutical aerosol formulations containing pre-micronized albuterol sulfate, high amount of green propellant trans-1,3,3,3-tetrafluoropropene (HFO-1234ze(E)), and a surfactant (polysorbate 80 (polyoxyethylene (20) sorbitan monooleate), polysorbate 20 (polyoxyethylene (20) sorbitan monolaurate), polyethylene glycol 1000, span 85 (sorbitan trioleate), polyvinylpyrrolidone K25, or their combination) in a pressurized metered dose inhaler are described. The formulations do not use any co-solvent, i.e., they are co-solvent-free (e.g., free of ethanol, glycerol, propylene glycol, and a combination thereof). The formulations provide highly efficient delivery, through metered dose inhaler (MDI), of pre-micronized albuterol particles into the patients' respiratory tracts and have the advantages of high efficacy, improved safety, and a low global warming potential (GWP) for environmental impact.


Find Patent Forward Citations

Loading…